What does CUSIP 75886F107 represent in this 13F holders report?

CUSIP 75886F107 is the security identifier for REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock in Q1 2020?

802 institutional investors reported REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock for Q1 2020. Use the holders table for investor-level position and value details.

REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)

CUSIP: 75886F107

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / Common Stock
Shares outstanding: 104,986,330
Total 13F shares: 75,018,948
Share change: +1,744,155
Total reported value: $36,621,954,337
Put/Call ratio: 92%
Price per share: $488.29
Number of holders: 802
Value change: +$962,200,288
Number of buys: 458
Number of sells: 325

Quarterly Holders Quick Answers

What is CUSIP 75886F107?
CUSIP 75886F107 identifies REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 75886F107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital World Investors	13F	Company	7.9%	8,332,424	$3,128,658,000	—	31 Dec 2019	13F
VANGUARD GROUP INC	13F	Company	6%	6,252,303	$2,347,615,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	5.8%	6,138,848	$2,305,015,000	—	31 Dec 2019	13F
HARRIS ASSOCIATES L P	13F	Company	4.2%	4,366,846	$1,639,663,000	—	31 Dec 2019	13F
LOOMIS SAYLES & CO L P	13F	Company	3.5%	3,692,675	$1,386,526,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	3.4%	3,574,117	$1,342,009,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	3.1%	3,225,827	$1,211,234,000	—	31 Dec 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.1%	2,249,915	$844,798,000	—	31 Dec 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.9%	1,952,557	$733,146,000	—	31 Dec 2019	13F
POLEN CAPITAL MANAGEMENT LLC	13F	Company	1.6%	1,676,294	$629,415,000	—	31 Dec 2019	13F
Capital International Investors	13F	Company	1.4%	1,517,433	$569,766,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	1,266,728	$474,673,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	1.2%	1,219,887	$458,045,000	—	31 Dec 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.1%	1,128,992	$423,913,000	—	31 Dec 2019	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.96%	1,009,435	$379,023,000	—	31 Dec 2019	13F
NORTHERN TRUST CORP	13F	Company	0.9%	946,596	$355,427,000	—	31 Dec 2019	13F
SANDS CAPITAL MANAGEMENT, LLC	13F	Company	0.81%	852,711	$320,176,000	—	31 Dec 2019	13F
NORGES BANK	13F	Company	0.78%	816,880	$306,722,000	—	31 Dec 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.75%	791,123	$297,051,000	—	31 Dec 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.75%	786,255	$295,223,000	—	31 Dec 2019	13F
Sustainable Growth Advisers, LP	13F	Company	0.65%	685,831	$257,516,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.65%	678,356	$254,709,000	—	31 Dec 2019	13F
FRANKLIN RESOURCES INC	13F	Company	0.63%	659,181	$247,509,000	—	31 Dec 2019	13F
HARDING LOEVNER LP	13F	Company	0.58%	607,342	$228,045,000	—	31 Dec 2019	13F
Bank of New York Mellon Corp	13F	Company	0.57%	600,673	$225,542,000	—	31 Dec 2019	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.52%	541,949	$203,491,000	—	31 Dec 2019	13F
Legal & General Group Plc	13F	Company	0.5%	522,294	$196,103,000	—	31 Dec 2019	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.45%	476,658	$178,976,000	—	31 Dec 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.45%	473,647	$177,841,000	—	31 Dec 2019	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.44%	465,823	$174,907,000	—	31 Dec 2019	13F
MORGAN STANLEY	13F	Company	0.44%	460,929	$173,071,000	—	31 Dec 2019	13F
S.c.a. Candriam	13F	Individual	0.39%	411,211	$154,402,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.38%	395,879	$148,645,000	—	31 Dec 2019	13F
HealthCor Management, L.P.	13F	Company	0.36%	372,770	$139,968,000	—	31 Dec 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.34%	356,916	$134,015,000	—	31 Dec 2019	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.33%	343,060	$128,706,000	—	31 Dec 2019	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.32%	331,250	$124,377,752	—	31 Dec 2019	13F
Neuberger Berman Group LLC	13F	Company	0.3%	318,437	$119,566,000	—	31 Dec 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.3%	316,312	$118,814,000	—	31 Dec 2019	13F
Invesco Ltd.	13F	Company	0.29%	309,355	$116,157,000	—	31 Dec 2019	13F
FIRST TRUST ADVISORS LP	13F	Company	0.29%	306,554	$115,105,000	—	31 Dec 2019	13F
LSV ASSET MANAGEMENT	13F	Company	0.29%	301,320	$113,139,000	—	31 Dec 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.27%	288,400	$108,288,000	—	31 Dec 2019	13F
Swiss National Bank	13F	Company	0.24%	255,422	$95,906,000	—	31 Dec 2019	13F
BARCLAYS PLC	13F	Company	0.23%	242,340	$90,993,000	—	31 Dec 2019	13F
CREDIT SUISSE AG/	13F	Company	0.21%	223,141	$83,784,000	—	31 Dec 2019	13F
ORBIMED ADVISORS LLC	13F	Company	0.2%	209,300	$78,588,000	—	31 Dec 2019	13F
NATIXIS ADVISORS, LLC	13F	Company	0.2%	208,670	$78,351,000	—	31 Dec 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.2%	206,700	$77,609,000	—	31 Dec 2019	13F
Tekla Capital Management LLC	13F	Company	0.19%	201,277	$75,575,000	—	31 Dec 2019	13F

Institutional Holders of REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) as of Q1 2020

As of 31 Mar 2020, REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) was held by 802 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 75,018,948 shares. The largest 10 holders included FMR LLC, Capital World Investors, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, LOOMIS SAYLES & CO L P, HARRIS ASSOCIATES L P, WELLINGTON MANAGEMENT GROUP LLP, ALLIANCEBERNSTEIN L.P., and POLEN CAPITAL MANAGEMENT LLC. This page lists 803 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

686

Q1 2020 holders

802

Holder diff

116

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.